CAR T-cell therapy is a type of immunotherapy used to treat multiple myeloma when other therapies have failed. It has improved remission and survival times, but long-term data on safety and success is ...
Information on the disease and treatments, assistance with insurance, and transportation are among the types of support needed by patients with multiple myeloma to improve outcomes and overall burden.
How Does Talvey Work for Multiple Myeloma? Talvey is a special type of molecule that can attach to two different types of cells. This is called a bispecific antibody. It attaches to GPRC5D proteins on ...
Speakers on precursor disease addressed distinctions between MGUS and smoldering multiple myeloma, risk stratification, and new thinking on the role of immunological aging, especially how it affects ...
How Does Darzalex Faspro Work for Multiple Myeloma? Darzalex Faspro is a type of medicine called a monoclonal antibody that is also known as a targeted therapy or an immunotherapy. It works by ...
MedPage Today on MSN
Zeroing in on the disparities in multiple myeloma care, outcomes
Estimates based on the most recent data from the NCI's Surveillance, Epidemiology, and End Results (SEER) program show that ...
Medical and health news service that features the most comprehensive coverage in the fields of neuroscience, cardiology, cancer, HIV/AIDS, psychology, psychiatry, dentistry, genetics, diseases and ...
While it’s not as well-known as, say, leukemia or melanoma, multiple myeloma is the second most common blood cancer in adults, according to the Cancer Research Institute. “Multiple myeloma is a cancer ...
The U.S. Food and Drug Administration approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results